Literature DB >> 21214253

Platensimycin and platencin congeners from Streptomyces platensis.

Chaowei Zhang1, John Ondeyka, Kithsiri Herath, Hiranthi Jayasuriya, Ziqiang Guan, Deborah L Zink, Lisa Dietrich, Bruce Burgess, Sookhee N Ha, Jun Wang, Sheo B Singh.   

Abstract

Platensimycin (1a) and platencin (2) are inhibitors of FabF and FabF/H bacterial fatty acid synthase. The discovery of natural congeners is an approach that can render a better understanding of the structure-function relationships of complex natural products. The isolation and structure elucidation of nine new congeners (11-20) of platensimycin and platencin are described from a fermentation broth of Streptomyces platensis. These hydroxylated congeners are likely derived by cytochrome P450 oxidation of the terpenoid units post-cyclization. Polar groups in the terpenoid portion of the molecule produce negative interactions with the hydrophobic pocket of FabF, resulting in poor activities. However, the discovery of these compounds serves an important purpose, not only to understand structure-function relationships, which cannot be easily accessed by chemical modification, but also to provide access to compounds that could be used for structural identification/confirmation of the oxidative trace metabolites produced in vivo during animal experiments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21214253     DOI: 10.1021/np100635f

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  15 in total

1.  Mechanisms of self-resistance in the platensimycin- and platencin-producing Streptomyces platensis MA7327 and MA7339 strains.

Authors:  Ryan M Peterson; Tingting Huang; Jeffrey D Rudolf; Michael J Smanski; Ben Shen
Journal:  Chem Biol       Date:  2014-02-20

2.  A Facile Semi-Synthetic Approach towards Halogen-Substituted Aminobenzoic Acid Analogues of Platensimycin.

Authors:  Lin Qiu; Kai Tian; Jian Pan; Lin Jiang; Hu Yang; Xiangcheng Zhu; Ben Shen; Yanwen Duan; Yong Huang
Journal:  Tetrahedron       Date:  2016-12-28       Impact factor: 2.457

Review 3.  Platensimycin and platencin: Inspirations for chemistry, biology, enzymology, and medicine.

Authors:  Jeffrey D Rudolf; Liao-Bin Dong; Ben Shen
Journal:  Biochem Pharmacol       Date:  2016-11-16       Impact factor: 5.858

4.  In vivo instability of platensimycin and platencin: Synthesis and biological evaluation of urea- and carbamate-platensimycin.

Authors:  Liao-Bin Dong; Jeffrey D Rudolf; Li Lin; Claudia Ruiz; Michael D Cameron; Ben Shen
Journal:  Bioorg Med Chem       Date:  2017-02-16       Impact factor: 3.641

Review 5.  Natural products: a continuing source of novel drug leads.

Authors:  Gordon M Cragg; David J Newman
Journal:  Biochim Biophys Acta       Date:  2013-02-18

6.  Total Syntheses and Biological Evaluation of (±)-Botryosphaeridione, (±)-Pleodendione, 4-epi-Periconianone B, and Analogues.

Authors:  Kishor L Handore; Prakash D Jadhav; Bibhabasu Hazra; Anirban Basu; D Srinivasa Reddy
Journal:  ACS Med Chem Lett       Date:  2015-09-28       Impact factor: 4.345

7.  Titer improvement and pilot-scale production of platensimycin from Streptomyces platensis SB12026.

Authors:  Jun Shi; Jian Pan; Ling Liu; Dong Yang; Songquan Lu; Xiangcheng Zhu; Ben Shen; Yanwen Duan; Yong Huang
Journal:  J Ind Microbiol Biotechnol       Date:  2016-04-28       Impact factor: 3.346

Review 8.  Novel Targets for Antimicrobials.

Authors:  Suchita Gupta; Vaishali Ravindra Undale; Kedar Lakhadive
Journal:  Turk J Pharm Sci       Date:  2020-10-30

9.  Design and Synthesis of Molecular Scaffolds with Anti-infective Activity.

Authors:  Junjia Liu; T Aaron Bedell; Julian G West; Erik J Sorensen
Journal:  Tetrahedron       Date:  2016-01-28       Impact factor: 2.457

10.  Semisynthesis and Biological Evaluation of Platencin Thioether Derivatives: Dual FabF and FabH Inhibitors against MRSA.

Authors:  Yuling Li; Xiang Weng; Youchao Deng; Jian Pan; Saibin Zhu; Zhongqing Wen; Yanqiu Yuan; Shaowen Li; Ben Shen; Yanwen Duan; Yong Huang
Journal:  ACS Med Chem Lett       Date:  2021-02-15       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.